Skip to main content
. 2015 Dec 1;10:64. doi: 10.1186/s13024-015-0059-y

Fig. 3.

Fig. 3

Alzheimer’s disease Specific Markers Graphs showing the results of the multiplexed MRM-based LC-MS/MS assay of protein biomarkers quantitated in the CSF of control. Lewy body dementia (LBD). Parkinson’s disease (PD) and Alzheimer’s disease (AD). All 4 markers show changes in AD specific from other neurodegenerative disease groups and controls. No significant changes are observed in the PD group * Denotes new marker not described previously

HHS Vulnerability Disclosure